Development Agreements in the Biotechnology Industry

607 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Master Services Agreement for Drug Product Development and Manufacturing between the Registrant and Lonza Ltd., dated March 22, 2022, as amended
Development Agreements
Vaxcyte, Inc.
Biotechnology
2022
Amendment No.3 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
Amendment No. 2 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
English Translation of Third Addendum to Product Development Agreement, dated October 16, 2024
Development Agreements
AMARILLO BIOSCIENCES INC
Biotechnology
2024
The Teaming Agreement between MRNA Scientific Sdn. Bhd. and Protech Builders Sdn. Bhd. for Biogas Plant Development, dated September 23, 2024
Development Agreements
BioNexus Gene Lab Coporation
Biotechnology
2024
Development and Manufacturing Services Agreement, dated February 28, 2012, by and between the Registrant and Minaris Regenerative Medicine, LLC (formerly known as Hitachi Advanced...
Development Agreements
bluebird bio, Inc.
Biotechnology
NY
2024
Second Amendment to Development Funding and Royalties Agreement, dated November 28, 2023, by and between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc
Development Agreements
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2024
First Amendment to Development Funding and Royalties Agreement, dated May 22, 2020, by and between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc
Development Agreements
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc
Development Agreements
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2024
English Translation of Second Addendum to Product Development Agreement, dated July 8, 2024
Development Agreements
AMARILLO BIOSCIENCES INC
Biotechnology
2024
Joint Development and Option Agreement, dated May 3, 2024, between the Company and The Cleveland Clinic Foundation. (Certain information has been redacted in the marked portions...
Development Agreements
Anixa Biosciences Inc
Biotechnology
OH
2024
Third Amendment to GPEx Development and Manufacturing Agreement dated as of April 11, 2022 between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC
Development Agreements
DiaMedica Therapeutics Inc.
Biotechnology
2024
Amendment No. 1 to Contract between the Company and the Biomedical Advanced Research and Development Authority, effective as of November 20, 2023
Development Agreements
Gritstone Oncology, Inc.
Biotechnology
2024
Amended and Restated Development Services and Clinical Supply Agreement, dated November 9, 2023, by and between the Registrant and Catalent Maryland, Inc
Development Agreements
Passage BIO, Inc.
Biotechnology
MD
2024
Amendment No. 2 to Development Funding and Royalties Agreement, dated as of November 29, 2023, by and between the Company and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2024
Amendment No. 1 to Development Funding and Royalties Agreement, dated as of May 22, 2020, by and between the Company and Palvella Therapeutics, Inc
Development Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2024
Master Services Agreement for Drug Product Development and Manufacturing between Registrant and Lonza Ltd., dated March 22, 2022, as amended
Development Agreements
Vaxcyte, Inc.
Biotechnology
2024
Amendment No. 1 to Amended and Restated Joint Development and Commercialization Agreement, dated December 23, 3023, between Vertex Pharmaceuticals Incorporated, Vertex...
Development Agreements
Vertex Pharmaceuticals Inc
Biotechnology
2024
English Translation of Addendum to the Product Development Agreement, dated on January 9, 2024
Development Agreements
AMARILLO BIOSCIENCES INC
Biotechnology
2024
English Translation of Product Development Agreement, dated on August 1, 2021
Development Agreements
AMARILLO BIOSCIENCES INC
Biotechnology
2024
Amendment No. 1 to the Amended and Restated Joint Development and Commercialization Agreement, dated December 12, 2023, by and between, on the one hand, Vertex Pharmaceuticals...
Development Agreements
CRISPR Therapeutics AG
Biotechnology
2023
Development and Manufacturing Services Agreement between Senti Biosciences, Inc. and GeneFab, LLC, dated August 7, 2023
Development Agreements
Dynamics Special Purpose Corp.
Biotechnology
DE
2023
Supplemental Agreement for nHCM, dated as of August 11, 2023, by and between MyoKardia, Inc., LianBio, LianBio Licensing, LLC, Lian Cardiovascular Limited, and Shanghai LianBio...
Development Agreements
LianBio
Biotechnology
NY
2023
Contract between the Company and the Biomedical Advanced Research and Development Authority, dated September 27, 2023
Development Agreements
Gritstone Oncology, Inc.
Biotechnology
2023
Amendment No. 1 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration for Strategic...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
Development and Supplemental Agreement between Elan Pharma International Limited and Acorda Therapeutics, Inc. dated January 14, 2011
Development Agreements
Alkermes plc.
Biotechnology
NY
2023
Commercial Agreement by and between the Company and the Lieber Institute for Brain Development dated October 13, 2023
Development Agreements
BullFrog AI Holdings, Inc.
Biotechnology
MD
2023
Development Agreement between Cardiff Oncology, Inc. and Pfizer, Inc. dated June 30, 2023
Development Agreements
Trovagene, Inc.
Biotechnology
NY
2023
Amendment of Solicitation/Modification of Contract, dated as of May 1, 2023 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S....
Development Agreements
T2 Biosystems, Inc.
Biotechnology
2023
Commercialization Agreement, dated as of December 16, 2022, by and among LianBio Development (HK) Limited, LianBio Respiratory Limited, ReViral Ltd. and Pfizer Inc
Development Agreements
LianBio
Biotechnology
NY
2023
Amendment Agreement No. 8 made and effective as of December 19, 2022 by and between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Development Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Amendment to Development and Licensing Agreement, by and between the Company and Robert One, LLC, dated December 9, 2022
Development Agreements
Eagle Pharmaceuticals, Inc.
Biotechnology
2022
Therapeutic Development Award Agreement, by and between Arrevus, Inc. and Cystic Fibrosis Foundation, dated December 13, 2021
Development Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2022
Amendment of Solicitation/Modification of Contract, dated as of September 29, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the...
Development Agreements
T2 Biosystems, Inc.
Biotechnology
2022
Amendment of Solicitation/Modification of Contract between the Biomedical Advanced Research and Development Authority and ContraFect Corporation, dated August 24, 2022
Development Agreements
CONTRAFECT Corp
Biotechnology
2022
Amendment of Solicitation/Modification of Contract dated September 29, 2015 between the registrant and the U.S Department of Health and Human Services Biomedical Advanced Research...
Development Agreements
Avita Therapeutics, Inc.
Biotechnology
2022
Amendment of Solicitation/Modification of Contract dated September 29, 2015 between the registrant and the U.S Department of Health and Human Services Biomedical Advanced Research...
Development Agreements
Avita Therapeutics, Inc.
Biotechnology
2022
Portfolio Development Advisor Agreement dated September 6, 2022 between KEWAT, LLC and Moleculin Biotech, Inc
Development Agreements
Moleculin Biotech, Inc.
Biotechnology
TX
2022
Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended
Development Agreements
Vaxcyte, Inc.
Biotechnology
2022
Cooperative Research and Development Agreement for Intramura-PhS Clinical Research
Development Agreements
Curative Biotechnology Inc
Biotechnology
2022